Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03JJW
|
|||
Drug Name |
PMID25522065-Compound-11
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ASTRAZENECA AB ASTRAZENECA UK LIMITED JOHANSSON, Lars, Anders, Mikael JUDKINS, Robert, Andrew LI, Lanna LOFBERG, Bjorn, Christian, Ingvar PERSSON, Joachim
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H23ClN4O4
|
|||
Canonical SMILES |
C1C(CN1C(=O)C2=NN=C(O2)C3=CC=C(C=C3)Cl)OC4=CC=C(C=C4)CN5CC6(C5)COC6
|
|||
InChI |
1S/C24H23ClN4O4/c25-18-5-3-17(4-6-18)21-26-27-22(33-21)23(30)29-10-20(11-29)32-19-7-1-16(2-8-19)9-28-12-24(13-28)14-31-15-24/h1-8,20H,9-15H2
|
|||
InChIKey |
OVCNWJXOBLGBEA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Antagonist | [1] |
Target's Patent Info | Melanin-concentrating hormone receptor 1 (MCHR1) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.